Missing-data in epidemiological studies of age-associated cognitive decline

Journal of the American Geriatrics Society

Volumn 47, Issue 11, 1999, Pages 1380-1381

  Di Bari, Mauro ^a   Williamson, Jeff ^b   Pahor, Marco ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b WAKE FOREST UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALZHEIMER DISEASE; COGNITIVE DEFECT; DEMENTIA; EDITORIAL; EPIDEMIOLOGY; HUMAN; MEDICAL RESEARCH; MENTAL HEALTH; PUBLIC HEALTH;

EID: 0032717344     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1999.tb07445.x     Document Type: Editorial

References (7)

1. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998;88:1337-1342.
2. Brayne C, Spiegelhalter D, Dufoil C et al. Estimating the true extent of cognitive decline in the old old. J Am Geriatr Soc 1999;47:0000-0000.
3. Boersma F, Eefsting JA, van den Brink W, van Tilburg W. Characteristics of non-responders and the impact of non-response on prevalence estimates of dementia. Int J Epidemiol 1997;26:1055-1062.
4. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
5. Applegate WB, Pressel S, Wittes J et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med 1994;154:2154-2160.
6. Di Bari M, Pahor M, Franse LV et al. Antihypertensive treatment and prevention of dementia in the Systolic Hypertension in the Elderly Program (SHEP) trial. Proceedings of the Annual Scientific Meeting of the Gerontological Society of America, San Francisco, 1999, in press.
7. Dorn H. Methods of analysis for follow-up studies. Human Biol 1950;22: 238-248.